VivoSeq
Other

Antibiotic Therapy

0

Pipeline Programs

11

Active Trials

1

Companies Involved

Antibiotic Therapy is an early-stage landscape with 0 programs across 1 company. The most active players are Merck & Co..

Pipeline Metrics

Competitive Density

28/100

Pipeline Velocity

6/100

Mech. Concentration

N/A

Completion Rate

84/100

Attrition Rate

8/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

36

clinical trials

Completed16 · 44%
Recruiting10 · 28%
Unknown status6 · 17%
Withdrawn2 · 6%
Active, not recruiting1 · 3%
Terminated1 · 3%

Trial Activity

36 trials

Page 1 of 3

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)